Global RNA Synthesis Market 2026 by Company, Regions, Type and Application, Forecast to 2032

1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Classification of RNA Synthesis by Type
  • 1.3.1 Overview: Global RNA Synthesis Market Size by Type: 2021 Versus 2025 Versus 2032
  • 1.3.2 Global RNA Synthesis Consumption Value Market Share by Type in 2025
  • 1.3.3 Transcription
  • 1.3.4 RNA Replication
• 1.4 Classification of RNA Synthesis by Product Function
  • 1.4.1 Overview: Global RNA Synthesis Market Size by Product Function: 2021 Versus 2025 Versus 2032
  • 1.4.2 Global RNA Synthesis Consumption Value Market Share by Product Function in 2025
  • 1.4.3 Coding RNA
  • 1.4.4 Non-coding RNA
• 1.5 Classification of RNA Synthesis by Synthesis Rate
  • 1.5.1 Overview: Global RNA Synthesis Market Size by Synthesis Rate: 2021 Versus 2025 Versus 2032
  • 1.5.2 Global RNA Synthesis Consumption Value Market Share by Synthesis Rate in 2025
  • 1.5.3 20~40 nt/s
  • 1.5.4 40~100 nt/s
  • 1.5.5 ＞100 nt/s
• 1.6 Global RNA Synthesis Market by Application
  • 1.6.1 Overview: Global RNA Synthesis Market Size by Application: 2021 Versus 2025 Versus 2032
  • 1.6.2 Biomedicine
  • 1.6.3 Molecular Diagnostics
  • 1.6.4 Agriculture
  • 1.6.5 Other
• 1.7 Global RNA Synthesis Market Size & Forecast
• 1.8 Global RNA Synthesis Market Size and Forecast by Region
  • 1.8.1 Global RNA Synthesis Market Size by Region: 2021 VS 2025 VS 2032
  • 1.8.2 Global RNA Synthesis Market Size by Region, (2021-2032)
  • 1.8.3 North America RNA Synthesis Market Size and Prospect (2021-2032)
  • 1.8.4 Europe RNA Synthesis Market Size and Prospect (2021-2032)
  • 1.8.5 Asia-Pacific RNA Synthesis Market Size and Prospect (2021-2032)
  • 1.8.6 South America RNA Synthesis Market Size and Prospect (2021-2032)
  • 1.8.7 Middle East & Africa RNA Synthesis Market Size and Prospect (2021-2032)

2 Company Profiles

• 2.1 Thermo Fisher Scientific
  • 2.1.1 Thermo Fisher Scientific Details
  • 2.1.2 Thermo Fisher Scientific Major Business
  • 2.1.3 Thermo Fisher Scientific RNA Synthesis Product and Solutions
  • 2.1.4 Thermo Fisher Scientific RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
  • 2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
• 2.2 Danaher
  • 2.2.1 Danaher Details
  • 2.2.2 Danaher Major Business
  • 2.2.3 Danaher RNA Synthesis Product and Solutions
  • 2.2.4 Danaher RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
  • 2.2.5 Danaher Recent Developments and Future Plans
• 2.3 Merck
  • 2.3.1 Merck Details
  • 2.3.2 Merck Major Business
  • 2.3.3 Merck RNA Synthesis Product and Solutions
  • 2.3.4 Merck RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
  • 2.3.5 Merck Recent Developments and Future Plans
• 2.4 Agilent Technologies
  • 2.4.1 Agilent Technologies Details
  • 2.4.2 Agilent Technologies Major Business
  • 2.4.3 Agilent Technologies RNA Synthesis Product and Solutions
  • 2.4.4 Agilent Technologies RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
  • 2.4.5 Agilent Technologies Recent Developments and Future Plans
• 2.5 Nitto Denko
  • 2.5.1 Nitto Denko Details
  • 2.5.2 Nitto Denko Major Business
  • 2.5.3 Nitto Denko RNA Synthesis Product and Solutions
  • 2.5.4 Nitto Denko RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
  • 2.5.5 Nitto Denko Recent Developments and Future Plans
• 2.6 ST Pharm
  • 2.6.1 ST Pharm Details
  • 2.6.2 ST Pharm Major Business
  • 2.6.3 ST Pharm RNA Synthesis Product and Solutions
  • 2.6.4 ST Pharm RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
  • 2.6.5 ST Pharm Recent Developments and Future Plans
• 2.7 WuXi AppTec
  • 2.7.1 WuXi AppTec Details
  • 2.7.2 WuXi AppTec Major Business
  • 2.7.3 WuXi AppTec RNA Synthesis Product and Solutions
  • 2.7.4 WuXi AppTec RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
  • 2.7.5 WuXi AppTec Recent Developments and Future Plans
• 2.8 GenScript Biotech
  • 2.8.1 GenScript Biotech Details
  • 2.8.2 GenScript Biotech Major Business
  • 2.8.3 GenScript Biotech RNA Synthesis Product and Solutions
  • 2.8.4 GenScript Biotech RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
  • 2.8.5 GenScript Biotech Recent Developments and Future Plans
• 2.9 TriLink
  • 2.9.1 TriLink Details
  • 2.9.2 TriLink Major Business
  • 2.9.3 TriLink RNA Synthesis Product and Solutions
  • 2.9.4 TriLink RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
  • 2.9.5 TriLink Recent Developments and Future Plans
• 2.10 Kaneka
  • 2.10.1 Kaneka Details
  • 2.10.2 Kaneka Major Business
  • 2.10.3 Kaneka RNA Synthesis Product and Solutions
  • 2.10.4 Kaneka RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
  • 2.10.5 Kaneka Recent Developments and Future Plans
• 2.11 BioSpring GmbH
  • 2.11.1 BioSpring GmbH Details
  • 2.11.2 BioSpring GmbH Major Business
  • 2.11.3 BioSpring GmbH RNA Synthesis Product and Solutions
  • 2.11.4 BioSpring GmbH RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
  • 2.11.5 BioSpring GmbH Recent Developments and Future Plans
• 2.12 Bachem Holding AG
  • 2.12.1 Bachem Holding AG Details
  • 2.12.2 Bachem Holding AG Major Business
  • 2.12.3 Bachem Holding AG RNA Synthesis Product and Solutions
  • 2.12.4 Bachem Holding AG RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
  • 2.12.5 Bachem Holding AG Recent Developments and Future Plans
• 2.13 Ajinomoto Bio-Pharma Services
  • 2.13.1 Ajinomoto Bio-Pharma Services Details
  • 2.13.2 Ajinomoto Bio-Pharma Services Major Business
  • 2.13.3 Ajinomoto Bio-Pharma Services RNA Synthesis Product and Solutions
  • 2.13.4 Ajinomoto Bio-Pharma Services RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
  • 2.13.5 Ajinomoto Bio-Pharma Services Recent Developments and Future Plans
• 2.14 Eurofins Genomics
  • 2.14.1 Eurofins Genomics Details
  • 2.14.2 Eurofins Genomics Major Business
  • 2.14.3 Eurofins Genomics RNA Synthesis Product and Solutions
  • 2.14.4 Eurofins Genomics RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
  • 2.14.5 Eurofins Genomics Recent Developments and Future Plans
• 2.15 Azenta
  • 2.15.1 Azenta Details
  • 2.15.2 Azenta Major Business
  • 2.15.3 Azenta RNA Synthesis Product and Solutions
  • 2.15.4 Azenta RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
  • 2.15.5 Azenta Recent Developments and Future Plans
• 2.16 Revvity
  • 2.16.1 Revvity Details
  • 2.16.2 Revvity Major Business
  • 2.16.3 Revvity RNA Synthesis Product and Solutions
  • 2.16.4 Revvity RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
  • 2.16.5 Revvity Recent Developments and Future Plans
• 2.17 LGC Biosearch Technologies
  • 2.17.1 LGC Biosearch Technologies Details
  • 2.17.2 LGC Biosearch Technologies Major Business
  • 2.17.3 LGC Biosearch Technologies RNA Synthesis Product and Solutions
  • 2.17.4 LGC Biosearch Technologies RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
  • 2.17.5 LGC Biosearch Technologies Recent Developments and Future Plans
• 2.18 Hongene Biotech
  • 2.18.1 Hongene Biotech Details
  • 2.18.2 Hongene Biotech Major Business
  • 2.18.3 Hongene Biotech RNA Synthesis Product and Solutions
  • 2.18.4 Hongene Biotech RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
  • 2.18.5 Hongene Biotech Recent Developments and Future Plans
• 2.19 Aldevron
  • 2.19.1 Aldevron Details
  • 2.19.2 Aldevron Major Business
  • 2.19.3 Aldevron RNA Synthesis Product and Solutions
  • 2.19.4 Aldevron RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
  • 2.19.5 Aldevron Recent Developments and Future Plans
• 2.20 Lonza Group
  • 2.20.1 Lonza Group Details
  • 2.20.2 Lonza Group Major Business
  • 2.20.3 Lonza Group RNA Synthesis Product and Solutions
  • 2.20.4 Lonza Group RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
  • 2.20.5 Lonza Group Recent Developments and Future Plans
• 2.21 Shanghai Jinsirui Vigorous Biotechnology
  • 2.21.1 Shanghai Jinsirui Vigorous Biotechnology Details
  • 2.21.2 Shanghai Jinsirui Vigorous Biotechnology Major Business
  • 2.21.3 Shanghai Jinsirui Vigorous Biotechnology RNA Synthesis Product and Solutions
  • 2.21.4 Shanghai Jinsirui Vigorous Biotechnology RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
  • 2.21.5 Shanghai Jinsirui Vigorous Biotechnology Recent Developments and Future Plans
• 2.22 PackGene Biotech
  • 2.22.1 PackGene Biotech Details
  • 2.22.2 PackGene Biotech Major Business
  • 2.22.3 PackGene Biotech RNA Synthesis Product and Solutions
  • 2.22.4 PackGene Biotech RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
  • 2.22.5 PackGene Biotech Recent Developments and Future Plans
• 2.23 Vernal Biosciences
  • 2.23.1 Vernal Biosciences Details
  • 2.23.2 Vernal Biosciences Major Business
  • 2.23.3 Vernal Biosciences RNA Synthesis Product and Solutions
  • 2.23.4 Vernal Biosciences RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
  • 2.23.5 Vernal Biosciences Recent Developments and Future Plans
• 2.24 Northern RNA
  • 2.24.1 Northern RNA Details
  • 2.24.2 Northern RNA Major Business
  • 2.24.3 Northern RNA RNA Synthesis Product and Solutions
  • 2.24.4 Northern RNA RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
  • 2.24.5 Northern RNA Recent Developments and Future Plans
• 2.25 MedTide Inc.
  • 2.25.1 MedTide Inc. Details
  • 2.25.2 MedTide Inc. Major Business
  • 2.25.3 MedTide Inc. RNA Synthesis Product and Solutions
  • 2.25.4 MedTide Inc. RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
  • 2.25.5 MedTide Inc. Recent Developments and Future Plans
• 2.26 Porton Pharma Solutions
  • 2.26.1 Porton Pharma Solutions Details
  • 2.26.2 Porton Pharma Solutions Major Business
  • 2.26.3 Porton Pharma Solutions RNA Synthesis Product and Solutions
  • 2.26.4 Porton Pharma Solutions RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
  • 2.26.5 Porton Pharma Solutions Recent Developments and Future Plans
• 2.27 Microsynth AG
  • 2.27.1 Microsynth AG Details
  • 2.27.2 Microsynth AG Major Business
  • 2.27.3 Microsynth AG RNA Synthesis Product and Solutions
  • 2.27.4 Microsynth AG RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
  • 2.27.5 Microsynth AG Recent Developments and Future Plans
• 2.28 Eton Bioscience
  • 2.28.1 Eton Bioscience Details
  • 2.28.2 Eton Bioscience Major Business
  • 2.28.3 Eton Bioscience RNA Synthesis Product and Solutions
  • 2.28.4 Eton Bioscience RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
  • 2.28.5 Eton Bioscience Recent Developments and Future Plans
• 2.29 Aurigene Pharmaceutical Services
  • 2.29.1 Aurigene Pharmaceutical Services Details
  • 2.29.2 Aurigene Pharmaceutical Services Major Business
  • 2.29.3 Aurigene Pharmaceutical Services RNA Synthesis Product and Solutions
  • 2.29.4 Aurigene Pharmaceutical Services RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
  • 2.29.5 Aurigene Pharmaceutical Services Recent Developments and Future Plans
• 2.30 Synbio Technologies
  • 2.30.1 Synbio Technologies Details
  • 2.30.2 Synbio Technologies Major Business
  • 2.30.3 Synbio Technologies RNA Synthesis Product and Solutions
  • 2.30.4 Synbio Technologies RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
  • 2.30.5 Synbio Technologies Recent Developments and Future Plans
• 2.31 biomers.net GmbH
  • 2.31.1 biomers.net GmbH Details
  • 2.31.2 biomers.net GmbH Major Business
  • 2.31.3 biomers.net GmbH RNA Synthesis Product and Solutions
  • 2.31.4 biomers.net GmbH RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
  • 2.31.5 biomers.net GmbH Recent Developments and Future Plans
• 2.32 Hunan Aikerui Bioengineering
  • 2.32.1 Hunan Aikerui Bioengineering Details
  • 2.32.2 Hunan Aikerui Bioengineering Major Business
  • 2.32.3 Hunan Aikerui Bioengineering RNA Synthesis Product and Solutions
  • 2.32.4 Hunan Aikerui Bioengineering RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
  • 2.32.5 Hunan Aikerui Bioengineering Recent Developments and Future Plans
• 2.33 Beijing Abace Biotechnology
  • 2.33.1 Beijing Abace Biotechnology Details
  • 2.33.2 Beijing Abace Biotechnology Major Business
  • 2.33.3 Beijing Abace Biotechnology RNA Synthesis Product and Solutions
  • 2.33.4 Beijing Abace Biotechnology RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
  • 2.33.5 Beijing Abace Biotechnology Recent Developments and Future Plans

3 Market Competition, by Players

• 3.1 Global RNA Synthesis Revenue and Share by Players (2021-2026)
• 3.2 Market Share Analysis (2025)
  • 3.2.1 Market Share of RNA Synthesis by Company Revenue
  • 3.2.2 Top 3 RNA Synthesis Players Market Share in 2025
  • 3.2.3 Top 6 RNA Synthesis Players Market Share in 2025
• 3.3 RNA Synthesis Market: Overall Company Footprint Analysis
  • 3.3.1 RNA Synthesis Market: Region Footprint
  • 3.3.2 RNA Synthesis Market: Company Product Type Footprint
  • 3.3.3 RNA Synthesis Market: Company Product Application Footprint
• 3.4 New Market Entrants and Barriers to Market Entry
• 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

• 4.1 Global RNA Synthesis Consumption Value and Market Share by Type (2021-2026)
• 4.2 Global RNA Synthesis Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

• 5.1 Global RNA Synthesis Consumption Value Market Share by Application (2021-2026)
• 5.2 Global RNA Synthesis Market Forecast by Application (2027-2032)

6 North America

• 6.1 North America RNA Synthesis Consumption Value by Type (2021-2032)
• 6.2 North America RNA Synthesis Market Size by Application (2021-2032)
• 6.3 North America RNA Synthesis Market Size by Country
  • 6.3.1 North America RNA Synthesis Consumption Value by Country (2021-2032)
  • 6.3.2 United States RNA Synthesis Market Size and Forecast (2021-2032)
  • 6.3.3 Canada RNA Synthesis Market Size and Forecast (2021-2032)
  • 6.3.4 Mexico RNA Synthesis Market Size and Forecast (2021-2032)

7 Europe

• 7.1 Europe RNA Synthesis Consumption Value by Type (2021-2032)
• 7.2 Europe RNA Synthesis Consumption Value by Application (2021-2032)
• 7.3 Europe RNA Synthesis Market Size by Country
  • 7.3.1 Europe RNA Synthesis Consumption Value by Country (2021-2032)
  • 7.3.2 Germany RNA Synthesis Market Size and Forecast (2021-2032)
  • 7.3.3 France RNA Synthesis Market Size and Forecast (2021-2032)
  • 7.3.4 United Kingdom RNA Synthesis Market Size and Forecast (2021-2032)
  • 7.3.5 Russia RNA Synthesis Market Size and Forecast (2021-2032)
  • 7.3.6 Italy RNA Synthesis Market Size and Forecast (2021-2032)

8 Asia-Pacific

• 8.1 Asia-Pacific RNA Synthesis Consumption Value by Type (2021-2032)
• 8.2 Asia-Pacific RNA Synthesis Consumption Value by Application (2021-2032)
• 8.3 Asia-Pacific RNA Synthesis Market Size by Region
  • 8.3.1 Asia-Pacific RNA Synthesis Consumption Value by Region (2021-2032)
  • 8.3.2 China RNA Synthesis Market Size and Forecast (2021-2032)
  • 8.3.3 Japan RNA Synthesis Market Size and Forecast (2021-2032)
  • 8.3.4 South Korea RNA Synthesis Market Size and Forecast (2021-2032)
  • 8.3.5 India RNA Synthesis Market Size and Forecast (2021-2032)
  • 8.3.6 Southeast Asia RNA Synthesis Market Size and Forecast (2021-2032)
  • 8.3.7 Australia RNA Synthesis Market Size and Forecast (2021-2032)

9 South America

• 9.1 South America RNA Synthesis Consumption Value by Type (2021-2032)
• 9.2 South America RNA Synthesis Consumption Value by Application (2021-2032)
• 9.3 South America RNA Synthesis Market Size by Country
  • 9.3.1 South America RNA Synthesis Consumption Value by Country (2021-2032)
  • 9.3.2 Brazil RNA Synthesis Market Size and Forecast (2021-2032)
  • 9.3.3 Argentina RNA Synthesis Market Size and Forecast (2021-2032)

10 Middle East & Africa

• 10.1 Middle East & Africa RNA Synthesis Consumption Value by Type (2021-2032)
• 10.2 Middle East & Africa RNA Synthesis Consumption Value by Application (2021-2032)
• 10.3 Middle East & Africa RNA Synthesis Market Size by Country
  • 10.3.1 Middle East & Africa RNA Synthesis Consumption Value by Country (2021-2032)
  • 10.3.2 Turkey RNA Synthesis Market Size and Forecast (2021-2032)
  • 10.3.3 Saudi Arabia RNA Synthesis Market Size and Forecast (2021-2032)
  • 10.3.4 UAE RNA Synthesis Market Size and Forecast (2021-2032)

11 Market Dynamics

• 11.1 RNA Synthesis Market Drivers
• 11.2 RNA Synthesis Market Restraints
• 11.3 RNA Synthesis Trends Analysis
• 11.4 Porters Five Forces Analysis
  • 11.4.1 Threat of New Entrants
  • 11.4.2 Bargaining Power of Suppliers
  • 11.4.3 Bargaining Power of Buyers
  • 11.4.4 Threat of Substitutes
  • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

• 12.1 RNA Synthesis Industry Chain
• 12.2 RNA Synthesis Upstream Analysis
• 12.3 RNA Synthesis Midstream Analysis
• 12.4 RNA Synthesis Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Research Process and Data Source